Know Cancer

or
forgot password

Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer


N/A
18 Years
N/A
Not Enrolling
Both
Pancreatic Cancer

Thank you

Trial Information

Minimally Invasive Detection of Lymphatic Micrometastases in Pancreatic Cancer


Inclusion Criteria:



- Patients with a mass in the pancreas suspicious for adenocarcinoma without biopsy
proven distant metastases.

- Patients who are scheduled for clinically indicated EUS

Exclusion Criteria:

- Patients who are medically unfit for endoscopic sedation or surgery due to severe
comorbid disease such as uncontrolled coronary disease, or oxygen dependant pulmonary
disease.

- Patients who have any other malignancy other than basal cell carcinoma within the
past 5 years.

Type of Study:

Observational

Study Design:

Observational Model: Case-Only, Time Perspective: Prospective

Outcome Measure:

To determine the if molecular biomarkers increase the sensitivity by at least 5% for detection of malignant lymph nodes in patients with pancreatic ductal adenocarcinoma as compared to EUS-FNA cytology of lymph nodes alone.

Outcome Time Frame:

End of study

Safety Issue:

No

Authority:

United States: Institutional Review Board

Study ID:

07-006640

NCT ID:

NCT00826982

Start Date:

January 2008

Completion Date:

Related Keywords:

  • Pancreatic Cancer
  • Pancreatic Neoplasms

Name

Location

Mayo ClinicJacksonville, Florida  32224